We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Novel Protein Biomarkers Linked to Risk of Developing Type I Diabetes

By LabMedica International staff writers
Posted on 22 Nov 2021
Print article
Image: Molecular model of chymotrypsinogen. Increased levels of chymotrypsinogen B1 (CTRB1) were associated with decreased risk of type I diabetes (Photo courtesy of Wikimedia Commons)
Image: Molecular model of chymotrypsinogen. Increased levels of chymotrypsinogen B1 (CTRB1) were associated with decreased risk of type I diabetes (Photo courtesy of Wikimedia Commons)
A recent study identified three novel circulating proteins associated with type I diabetes risk and that could potentially serve as diagnostic biomarkers for the disease.

Type I diabetes is an autoimmune disease that developes when very little or no insulin is produced by the islets of Langerhans (containing beta cells) in the pancreas. This type affects about 10% of people living with diabetes, but few biomarkers have been found that are able to predict the risk of developing the disease.

To rectify this situation, investigators at the University of Montreal (Canada) conducted a large-scale two-sample Mendelian randomization (MR) study of up to 1,611 circulating proteins from five large genome-wide association studies to screen for causal associations of these proteins with type I diabetes risk in 9,684 case subjects with type I diabetes and 15,743 control subjects.

The investigators found that a genetically predicted SD (standard deviation) increase in the level of signal regulatory protein gamma (SIRPG) was associated with increased risk of type I diabetes risk. SIRPG is a member of the signal-regulatory protein (SIRP) family, and also belongs to the immunoglobulin superfamily. SIRP family members are receptor-type transmembrane glycoproteins known to be involved in the negative regulation of receptor tyrosine kinase-coupled signaling processes.

Results also showed that the risk of type I diabetes nearly doubled for every genetically predicted SD increase in interleukin-27 Epstein-Barr virus–induced 3 (IL27-EBI3) protein levels. In contrast, an SD increase in chymotrypsinogen B1 (CTRB1) was associated with decreased risk of type I diabetes. Chymotrypsinogen is an inactive precursor of the digestive enzyme chymotrypsin. It comprises a single 245 amino acid residue polypeptide chain, which is synthesized in the acinar cells of the pancreas.

"Our analyses revealed that higher levels of SIRPG and IL27EBI3 proteins increase the risk of developing type I diabetes and higher levels of CTRB1 decrease the risk of developing the disease," said senior author Dr. Despoina Manousaki, clinical assistant professor of pediatrics at the University of Montreal. "Based on our results, we observe that an increase in plasma SIRPG is associated with an almost 60% increase in the risk of developing type I diabetes, while an increase in IL27EBI3 doubles the risk. Conversely, a higher CTRB1 level has a protective effect with a nearly 20% decrease in the risk of developing the disease. We need further research to validate these candidate proteins in case-controlled cohorts of type I diabetes, but these proteins have the potential to advance precision medicine for individuals at risk of developing this condition."

The study was published in the November 10, 2021, online edition of the journal Diabetes Care.

Related Links:
University of Montreal

Gold Supplier
Automated Immune Analyzer
UNION Immune Analyzer
New
Lateral Flow Test Cassette Reader
Quantum Blue III
New
SARS-CoV-2 Antigen Test
Actim SARS-CoV-2
New
Silver Supplier
Bacteriuria Test Strips
MAST Bacteruritest Strips

Print article

Channels

Hematology

view channel
Image: The Gazelle Hb Variant Test for screening, diagnosis and management of sickle cell disease and related hemoglobinopathies at the point of care (Photo courtesy of Hemex Health)

Point-of-Care Device Accurately Rapidly Diagnoses Sickle Cell Disease

Hemoglobinopathies are the most common autosomal hereditary disorders. Approximately 7% of the global population carries hemoglobin gene mutation including structural hemoglobin variants like sickle hemoglobin... Read more

Immunology

view channel
Image: The IMMULITE 2000 XPi Immunoassay System provides multiple tests on a single, easy-to-use analyzer, including the thyroid-stimulating immunoglobulin assay (Photo courtesy of Siemens Healthcare)

Immunoassays Evaluated for Thyroid-Stimulating Receptor Antibody in Graves’ Disease

Graves' disease (GD), also known as toxic diffuse goiter, is an autoimmune disease that affects the thyroid. It frequently results in and is the most common cause of hyperthyroidism and it also often results... Read more

Microbiology

view channel
Image: The sciREADER CL2 enables high quality digital colorimetric imaging of various support formats (Photo courtesy of SCIENION)

Multiplex Immunoassay Developed for Confirmation and Typing of HTLV Infections

Human T-Cell Lymphotropic Viruses (HTLV) type 1 and type 2 account for an estimated five to 10 million infections worldwide and are transmitted through breast feeding, sexual contacts and contaminated... Read more

Pathology

view channel
Illustration

AI Accurately Detects and Diagnoses Colorectal Cancer from Tissue Scans As Well or Better Than Pathologists

Artificial intelligence (A) can accurately detect and diagnose colorectal cancer from tissue scans as well or better than pathologists, according to a new study. The study, which was conducted by researchers... Read more

Technology

view channel
Image: PKeye Workflow Monitor System (Photo courtesy of PerkinElmer, Inc.)

PerkinElmer’s New Cloud-Based Platform Enables Laboratory Personnel to Remotely Manage Its Instruments in Real-Time

PerkinElmer, Inc. (Waltham, MA; USA) has launched its PKeye Workflow Monitor, a cloud-based platform enabling laboratory personnel to remotely manage and monitor their PerkinElmer instruments and workflows... Read more

Industry

view channel
Illustration

Global Point of Care Diagnostics Market to Top USD 35 Billion by 2027 Due to Rising Diabetic Cases

The global point of care diagnostics market is projected to grow at a CAGR of close to 6% from more than USD 23 billion in 2020 to over USD 35 billion by 2027, driven by an increase in the number of diabetic... Read more
Copyright © 2000-2021 Globetech Media. All rights reserved.